Lompostran

Lompostran

We pair our expertise with your vision to bring your products to the market.

Founded 2020

Portugal 3 employees Analytics, Biotechnology +1

Lompostran is a Portugal-based startup with a vision to become a global leader in the production of high-quality, safe, and efficacious cannabis-derived products. Their founded in 2020, and they aim to support the current market demand for EU-GMP dried flower and the ongoing shift from the use of cannabis flower to pharmaceutical-grade finished dosage forms. Lompostran strategically positions itself to be a critical partner/service provider in the Portuguese supply chain of Medicinal Cannabis products to serve the EU Market. Their industries include Analytics, Biotechnology, and Manufacturing. They offer contract manufacturing services such as drying, sanitization, packaging, storage, analysis, and batch disposition of cannabis-based products, creating a pathway for all Portuguese cultivators to access the European Medical market without the need for large CAPEX investment, staffing, and infrastructure. Lompostran's scalable, flexible process solutions allow them to manufacture tailored products from cannabis plant material, which would otherwise not meet the quality requirements of the EU medical cannabis market. They aim to pair their expertise with their client’s vision to bring their products to the market. Additionally, their fully integrated solutions enable cultivators to transform GACP Cannabis to a pharmaceutical (GMP) product by availing themselves of their contract manufacturing services, all while adhering to pharmaceutical industry standards and controls. Currently, there is no information available regarding their last investment or investors.

FAQ About Lompostran

We pair our expertise with your vision to bring your products to the market.

Lompostran was founded in 2020.

Lompostran is headquartered in Portugal.

Lompostran operates in Analytics, Biotechnology and Manufacturing. Its work centres on Medical Cannabis, EU-GMP Compliance, Cannabis-derived Products and Contract Manufacturing.

Lompostran has approximately 3 employees.

Top alternatives and competitors to Lompostran include Psygen, GESLabs, Pacific Pharmaceuticals, Burrard Pharmaceuticals, Omrix Biopharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Lompostran and Psygen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Lompostran

Lompostran Alternatives & Competitors

FAQ About Lompostran